title: Electrophysiological effects of the antiarrhythmic agent GYKI-23107 in dogs.
abstract: Cardiac electrophysiological properties of GYKI-23107, a new membrane stabilizing antiarrhythmic agent were studied in anaesthetized open-chest dogs. Epi- end endocardial electrograms (for sinus potential and for His bundle recording) were obtained during sinus rhythm and following atrial and ventricular pacing. The registration were performed under control conditions as well as five minutes after drug administration of 8 mg/kg slow i.v. or 20 minutes after 20 mg/kg intraduodenal administration respectively. GYKI-23107 did not influence significantly either the sinus cycles, PA-intervals, sinus node potentials, or the classical electrophysiological parameters of sinoatrial function as the corrected recovery time of the sinus node, sino-atrial conduction time or the secondary post-stimulation sinus cycles before and after vegetative blockade. Neither the AH intervals, anterograde Wenckebach period, nor ventriculo-atrial conduction time changed significantly. QRS duration, configuration and HV-intervals remained also unchanged after drug administration in doses which used in this study, and which seemed to be in therapeutic range. The agent did not influence significantly the effective refractory periods of the atrium and ventricle during sinus rhythm. This study suggest that the GYKI-23107 is not depressive on the anterograde (AV), retrograde (VA), intraventricular conduction and is slightly depressive on the intrinsic pacemaker properties.
authors.affiliation: Institute for Drug Research, University Hospital, Semmelweis University Medical School, Budapest, Hungary.
authors.forename: L J
authors.initials: LJ
authors.lastname: Szatmary
authors.forename: G
authors.initials: G
authors.lastname: Rabloczky
authors.forename: M
authors.initials: M
authors.lastname: Kurthy
authors.forename: A
authors.initials: A
authors.lastname: Varro
authors.forename: F
authors.initials: F
authors.lastname: Solti
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D016275:Atrial Function; D004285:Dogs; D004569:Electroencephalography; D005260:Female; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D008297:Male; D011437:Propylamines / Q000494:pharmacology*; D012849:Sinoatrial Node / Q000502:physiology; D016276:Ventricular Function
chemical_list: D000889:Anti-Arrhythmia Agents; D011437:Propylamines; C052565:GYKI 23107